Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01401985
PHASE2
A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
Sponsor: Glycyx Therapeutics
View on ClinicalTrials.gov
Summary
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation
Official title: A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
95
Start Date
2011-10
Completion Date
2012-08
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
TD-1211
Capsules
DRUG
Placebo
Capsules
Locations (1)
Theravance Biopharma Investigational Site
Pasadena, California, United States